Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunocore Holdings Plc ADR (NQ: IMCR )

63.30 -0.99 (-1.54%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 201,205
Open 64.27
Bid (Size) 55.10 (1)
Ask (Size) 101.28 (2)
Prev. Close 64.29
Today's Range 61.40 - 64.63
52wk Range 21.00 - 69.06
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via Globe NewsWire
3 Pharma Stocks That Will Mint Millionaires
These pharma stocks all have excellent risk-reward ratios and the companies have developed treatments that could easily become blockbusters. 
Via InvestorPlace

Performance

YTD
+14.22%
+14.22%
1 Month
+23.08%
+23.08%
3 Month
+13.71%
+13.71%
6 Month
+16.57%
+16.57%
1 Year
+152.29%
+152.29%

More News

Read More
Immunocore announces strategic priorities including pipeline expansion for 2023 -2024
From Immunocore Holdings Limited
Via Globe NewsWire
Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference
From Immunocore Holdings Limited
Via Globe NewsWire
Analyst Ratings for Immunocore Hldgs
Via Benzinga
Where Immunocore Hldgs Stands With Analysts
Via Benzinga
7 Analysts Have This to Say About Immunocore Hldgs
Via Benzinga
Where Immunocore Hldgs Stands With Analysts
Via Benzinga
What 6 Analyst Ratings Have To Say About Immunocore Hldgs
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
Via Benzinga
Immunocore is awarded the Prix Galien France award for KIMMTRAK
From Immunocore Holdings Limited
Via Globe NewsWire
5 Analysts Have This to Say About Immunocore Hldgs
Via Benzinga
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
From Immunocore Holdings Limited
Via Globe NewsWire
Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
From Immunocore Holdings Limited
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
Via Benzinga
Immunocore to present at the 5th Annual Evercore ISI HealthCONx Conference
From Immunocore Holdings Limited
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Procter & Gamble To Jump Over 16%? Here Are 5 Other Price Target Changes For Monday
Via Benzinga
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
Via Benzinga
Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
From Immunocore Holdings Limited
Via Globe NewsWire
Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
Via MarketBeat
Immunocore to present at the Jefferies London Healthcare Conference
From Immunocore Holdings Limited
Via Globe NewsWire
Immunocore Reports Third Quarter 2022 Financial Results and Provides Business Update
From Immunocore Holdings Limited
Via Globe NewsWire
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
Via Benzinga
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.